Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
Stopped early · Phase 1/Phase 2
Conditions studied: Head and Neck Cancer
In brief
The purpose of this study is to find out whether adding ZD1839 to standard treatment (Cisplatin and Radiation Therapy) of unresectable head and neck cancers is better than cisplatin and radiation alone.
Key facts
- Study ID
- NCT00195078
- Run by
- Weill Medical College of Cornell University
- People needed
- 29
- Starts
- 2004-04-01
- Expected to finish
- 2006-09-01
- Last updated by the study team
- 2007-07-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically confirmed squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx. For the Phase II portion of the study: measurable disease as based on RECIST criteria.
- Stage III or IV disease, M0.
- Life expectancy > 6 months.
You may not qualify if…
- Known severe hypersensitivity to ZD1839 or any of the excipients of this product.
- Other co-existing malignancies or malignancies diagnosed within the last 5 years, with the exception of squamous cell carcinoma of the skin or cervical cancer in situ.
- Previous treatment with radiation, chemotherapy, or definitive surgical therapy.
- Distant metastatic disease.
- Documented evidence of HIV infection (because the interaction of ZD1839 with Highly Active Anti-Retroviral Therapy [HAART] is unknown).
- Substance abuse or psychiatric problems that would interfere with compliance.
- Pregnancy or breast-feeding (women of child-bearing potential).
- Treatment with a non-approved or investigational drug within 30 days before Day 1 of study treatment.
- Any evidence of clinically active interstitial lung disease (patients with chronic stable radiographic changes who are asymptomatic need not be excluded)
Where it is running
- Weill Medical College of Cornell University — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.